Inventor
Brian Safina
Inventor
South San Francisco, CA, US
Overview
Patents· 42 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes23%
C07CAcyclic or carbocyclic compounds6%
C07KPeptides5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C07BGeneral methods of organic chemistry2%
C07HSugars1%
PatentTitleYear
11,130,726Therapeutic compounds and methods of use thereof202110,947,251Therapeutic compounds and methods of use thereof202110,899,732Substituted benzamides useful as sodium channel blockers202110,787,446Therapeutic compounds and methods of use thereof202010,711,004Oxadiazole transient receptor potential channel inhibitors202010,632,210Peptidomimetic compounds and antibody-drug conjugates thereof202010,544,2151-(Chloromethyl)-2,3-dihydro-1H-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment202010,533,058Peptidomimetic compounds and antibody-drug conjugates thereof202010,526,285Therapeutic compounds and methods of use thereof202010,442,8361-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate compounds, and methods of use and treatment201910,179,767Substituted benzamides and methods of use thereof201910,124,069Peptidomimetic compounds and antibody-drug conjugates thereof201810,125,098Therapeutic compounds and methods of use thereof201810,071,957N-substituted benzamides and methods of use thereof201810,005,724Therapeutic compounds and methods of use thereof20189,999,681Peptidomimetic compounds and antibody-drug conjugates thereof20189,771,376'N-substituted benzamides and methods of use thereof'20179,694,002'Substituted benzamides and methods of use thereof'20179,550,775'Substituted triazolopyridines and methods of use thereof'20179,546,164'Substituted benzamides and methods of use thereof'20179,409,886'Pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20169,359,340'Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors'20169,090,628'Benzoxazepin compounds selective for PI3K P110 delta and methods of use'20158,952,169'N-substituted benzamides and methods of use thereof'20158,933,236'N-substituted benzamides and methods of use thereof'20158,853,216'Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor'20148,853,199'Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20148,846,681'Pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20148,846,683'Pyrimidyl cyclopentanes as Akt protein kinase inhibitors'20148,835,434'Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors'20148,653,089'Heterocyclic compounds and methods of use'20148,618,097'Pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20138,563,540'Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of use'20138,440,651'Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of use'20138,394,796'Bicyclic pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use'20138,377,937'Pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20138,293,736'Purine compounds selective for PI3K P110 delta, and methods of use'20128,173,650'Bicyclic pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use'20128,158,625'Bicyclic indole-pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use'20128,063,050'Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20118,003,651'Pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20117,749,994'Pentacyclic kinase inhibitors'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2021Patents assigned to GENENTECH INC (38)· patent assignee history
2010–2020Based in Redwood City, CA, US· patent location history
2011–2015Patents assigned to SAFINA BRIAN (12)· patent assignee history
2011–2016Patents assigned to ARRAY BIOPHARMA INC (11)· patent assignee history
2011–2014Patents assigned to BLAKE JAMES F (7)· patent assignee history
2014–2021Based in South San Francisco, CA, US· patent location history
2015–2021Patents assigned to XENON PHARMACEUTICALS INC (14)· patent assignee history
2015Based in San Francisco, CA, US· patent location history
2019Based in Belmont, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENENTECH INC | 38 | 2010–2021 |
| XENON PHARMACEUTICALS INC | 14 | 2015–2021 |
| SAFINA BRIANself | 12 | 2011–2015 |
| ARRAY BIOPHARMA INC | 11 | 2011–2016 |
| BLAKE JAMES F | 7 | 2011–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| South San Francisco, California, US | 23 | 2014–2021 |
| Redwood City, California, US | 17 | 2010–2020 |
| Belmont, California, US | 1 | 2019 |
| San Francisco, California, US | 1 | 2015 |